NEXUS Biosystems Acquired

According to an SEC filing, Telegraph Hill purchased the equity holding for $5 million. NEXUS Biosystems stated that the company also plans to use the financing to expand its customer support and manufacturing capabilities.

Poway, CA 7/7/09—Private equity firm Telegraph Hill Partners has purchased a majority stake in NEXUS Biosystems, a provider of automated sample management systems. The majority equity and growth financing will be used to commercialize NEXUS’s new series of -80°C BioStores. Deval Lashkari, PhD, and Glenn Novotny, both partners in Telegraph Hill, will join the company’s board of directors.

< | >